Molecular genetic characterization reveals new subsets of mantle cell lymphoma

Leukemia and Lymphoma

Volumn 49, Issue 6, 2008, Pages 1042-1049

  Thelander, Emma Flordal ^a   Rosenquist, Richard ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Array CGH; Genomic imbalances; IGHV3 21 gene usage; Immunoglobulin genes; Mantle cell lymphoma; Somatic hypermutation

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN HEAVY CHAIN [3-21]; IMMUNOGLOBULIN HEAVY CHAIN [4-34]; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN LIGHT CHAIN [3-19];

ANTIGEN RECOGNITION; B LYMPHOCYTE; CANCER SURVIVAL; CARCINOGENESIS; CELL MATURATION; CHROMOSOME 15Q; CHROMOSOME 9P; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; GENE LOSS; GENE MUTATION; GENE REARRANGEMENT; GENETIC GAIN; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; LYMPHOCYTE MIGRATION; MANTLE CELL LYMPHOMA; MOLECULAR CLONING; MOLECULAR GENETICS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; TUMOR DIFFERENTIATION;

GENES, IMMUNOGLOBULIN; HUMANS; LYMPHOMA, MANTLE-CELL; MOLECULAR BIOLOGY; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 46749155542     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190801947559     Document Type: Review

References (65)

1. Argatoff, L. H., Connors, J. M., Klasa, R. J., Horsman, D. E. and Gascoyne, R. D. (1997) Mantle cell lymphoma: A clinicopathologic study of 80 cases. Blood, 89, pp. 2067-2078.
2. (2001) IARC Press, Lyon
3. Howard, O. M., Gribben, J. G., Neuberg, D. S., Grossbard, M., Poor, C. Janicek, M. J. et al. (2002) Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: Molecular complete responses are not predictive of progression-free survival. J Clin Oncol, 20, pp. 1288-1294.
4. Dreyling, M., Lenz, G., Hoster, E., Van Hoof, A., Gisselbrecht, C. Schmits, R. et al. (2005) Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: Results of a prospective randomized trial of the European MCL Network. Blood, 105, pp. 2677-2684.
5. Lenz, G., Dreyling, M., Hoster, E., Wormann, B., Duhrsen, U. Metzner, B. et al. (2005) Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: Results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). J Clin Oncol, 23, pp. 1984-1992.
6. Witzig, T. E. (2005) Current treatment approaches for mantle-cell lymphoma. J Clin Oncol, 23, pp. 6409-6414.
7. Leonard, J. P., Furman, R. R. and Coleman, M. (2006) Proteasome inhibition with bortezomib: A new therapeutic strategy for non-Hodgkin's lymphoma. Int J Cancer, 119, pp. 971-979.
8. Greiner, T. C., Moynihan, M. J., Chan, W. C., Lytle, D. M., Pedersen, A. Anderson, J. R. et al. (1996) p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood, 87, pp. 4302-4310.
9. Hernandez, L., Fest, T., Cazorla, M., Teruya-Feldstein, J., Bosch, F. Peinado, M. A. et al. (1996) p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood, 87, pp. 3351-3359.
10. Bea, S., Ribas, M., Hernandez, J. M., Bosch, F., Pinyol, M. Hernandez, L. et al. (1999) Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood, 93, pp. 4365-4374.
11. Swerdlow, S. H. and Williams, M. E. (2002) From centrocytic to mantle cell lymphoma: A clinicopathologic and molecular review of 3 decades. Hum Pathol, 33, pp. 7-20.
12. Gladden, A. B. and Diehl, J. A. (2005) Location, location, location: The role of cyclin D1 nuclear localization in cancer. J Cell Biochem, 96, pp. 906-913.
13. Gladden, A. B., Woolery, R., Aggarwal, P., Wasik, M. A. and Diehl, J. A. (2006) Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma. Oncogene, 25, pp. 998-1007.
14. Fu, K., Weisenburger, D. D., Greiner, T. C., Dave, S., Wright, G. Rosenwald, A. et al. (2005) Cyclin D1-negative mantle cell lymphoma: A clinicopathologic study based on gene expression profiling. Blood, 106, pp. 4315-4321.
15. Salaverria, I., Zettl, A., Bea, S., Moreno, V., Valls, J. Hartmann, E. et al. (2007) Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. J Clin Oncol, 25, pp. 1216-1222.
16. Raty, R., Franssila, K., Joensuu, H., Teerenhovi, L. and Elonen, E. (2002) Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma. Eur J Haematol, 69, pp. 11-20.
17. Rosenwald, A., Wright, G., Wiestner, A., Chan, W. C., Connors, J. M. Campo, E. et al. (2003) The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell, 3, pp. 185-197.
18. Flordal Thelander, E, Ichimura, K., Collins, V. P., Walsh, S. H., Barbany, G. Hagberg, A. et al. (2007) Detailed assessment of copy number alterations revealing homozygous deletions in lp and 13q in mantle cell lymphoma. Leuk Res, 31, pp. 1219-1230.
19. Fugmann, S. D., Lee, A. I., Shockett, P. E., Villey, I. J. and Schatz, D. G. (2000) The RAG proteins and V(D)J recombination: Complexes, ends, and transposition. Annu Rev Immunol, 18, pp. 495-527.
20. Lewis, S. M. (1994) The mechanism of V(D)J joining: Lessons from molecular, immunological, and comparative analyses. Adv Immunol, 56, pp. 27-150.
21. Papavasiliou, F. N. and Schatz, D. G. (2002) Somatic hypermutation of immunoglobulin genes: Merging mechanisms for genetic diversity. Cell, 109, pp. S35-S44.
22. Rada, C., Williams, G. T., Nilsen, H., Barnes, D. E., Lindahl, T. and Neuberger, M. S. (2002) Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr Biol, 12, pp. 1748-1755.
23. Kuppers, R., Klein, U., Hansmann, M. L. and Rajewsky, K. (1999) Cellular origin of human B-cell lymphomas. N Engl J Med, 341, pp. 1520-1529.
24. Bird, J., Galili, N., Link, M., Stites, D. and Sklar, J. (1988) Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia. J Exp Med, 168, pp. 229-245.
25. Bahler, D. W., Campbell, M. J., Hart, S., Miller, R. A., Levy, S. and Levy, R. (1991) Ig VH gene expression among human follicular lymphomas. Blood, 78, pp. 1561-1568.
26. Kuppers, R., Rajewsky, K. and Hansmann, M. L. (1997) Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression. Eur J Immunol, 27, pp. 1398-1405.
27. Lossos, I. S., Alizadeh, A. A., Eisen, M. B., Chan, W. C., Brown, P. O. Botstein, D. et al. (2000) Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci USA, 97, pp. 10209-10213.
28. Rettig, M. B., Vescio, R. A., Cao, J., Wu, C. H., Lee, J. C. Han, E. et al. (1996) VH gene usage is multiple myeloma: Complete absence of the VH4.21 (VH4-34) gene. Blood, 87, pp. 2846-2852.
29. Damle, R. N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A. Allen, S. L. et al. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, pp. 1840-1847.
30. Hamblin, T. J., Davis, Z., Gardiner, A., Oscier, D. G. and Stevenson, F. K. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, pp. 1848-1854.
31. Chiorazzi, N., Rai, K. R. and Ferrarini, M. (2005) Chronic lymphocytic leukemia. N Engl J Med, 352, pp. 804-815.
32. Walsh, S. H. and Rosenquist, R. (2005) Immunoglobulin gene analysis of mature B-cell malignancies: Reconsideration of cellular origin and potential antigen involvement in pathogenesis. Med Oncol, 22, pp. 327-341.
33. Camacho, F. I., Algara, P., Rodriguez, A., Ruiz-Ballesteros, E., Mollejo, M. Martinez, N. et al. (2003) Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations. Blood, 101, pp. 4042-4046.
34. Kienle, D., Krober, A., Katzenberger, T., Ott, G., Leupolt, E. Barth, T. F. et al. (2003) VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: Correlation with genomic aberrations, clinical characteristics, and outcome. Blood, 102, pp. 3003-3009.
35. Walsh, S. H., Thorselius, M., Johnson, A., Soderberg, O., Jerkeman, M. Bjorck, E. et al. (2003) Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma. Blood, 101, pp. 4047-4054.
36. Lai, R., Lefresne, S. V., Franko, B., Hui, D., Mirza, I. Mansoor, A. et al. (2006) Immunoglobulin VH somatic hypermutation in mantle cell lymphoma: Mutated genotype correlates with better clinical outcome. Mod Pathol, 19, pp. 1498-1505.
37. Orchard, J., Garand, R., Davis, Z., Babbage, G., Sahota, S. Matutes, E. et al. (2003) A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood, 101, pp. 4975-4981.
38. Inagaki, H., Nakamura, T., Li, C., Sugiyama, T., Asaka, M. Kodaira, J. et al. (2004) Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter pylori eradication and detection of API2-MALT1 fusion. Am J Surg Pathol, 28, pp. 1560-1567.
39. Du, M. Q. (2007) MALT Lymphoma: Recent advances in aetiology and molecular genetics. J Clin Exp Hematop, 47, pp. 31-42.
40. Viswanatha, D. S. and Dogan, A. (2007) Hepatitis C virus and lymphoma. J Clin Pathol, 60, pp. 1378-1383.
41. Johnson, T. A., Rassenti, L. Z. and Kipps, T. J. (1997) Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol, 158, pp. 235-246.
42. Fais, F., Ghiotto, F., Hashimoto, S., Sellars, B., Valetto, A. Allen, S. L. et al. (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest, 102, pp. 1515-1525.
43. Rosenquist, R., Lindstrom, A., Holmberg, D., Lindh, J. and Roos, G. (1999) V(H) gene family utilization in different B-cell lymphoma subgroups. Eur J Haematol, 62, pp. 123-128.
44. Tobin, G., Thunberg, U., Johnson, A., Eriksson, I., Soderberg, O. Karlsson, K. et al. (2003) Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: Implicating recognition of a common antigen epitope. Blood, 101, pp. 4952-4957.
45. Thorselius, M., Walsh, S., Eriksson, I., Thunberg, U., Johnson, A. Backlin, C. et al. (2002) Somatic hypermutation and V(H) gene usage in mantle cell lymphoma. Eur J Haematol, 68, pp. 217-224.
46. Fang, Q., Kannapell, C. C., Gaskin, F., Solomon, A., Koopman, W. J. and Fu, S. M. (1994) Human rheumatoid factors with restrictive specificity for rabbit immunoglobulin G: Auto- and multi-reactivity, diverse VH gene segment usage and preferential usage of V lambda IIIb. J Exp Med, 179, p. 1445.
47. Elagib, K. E., Tengner, P., Levi, M., Jonsson, R., Thompson, K. M. Natvig, J. B. et al. (1999) Immunoglobulin variable genes and epitope recognition of human monoclonal anti-Ro 52-kd in primary Sjogren's syndrome. Arthritis Rheum, 42, pp. 2471-2481.
48. Cappione, A. J., Pugh-Bernard, A. E., Anolik, J. H. and Sanz, I. (2004) Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes. J Immunol, 172, pp. 4298-4307.
49. Tobin, G., Thunberg, U., Johnson, A., Thorn, I., Soderberg, O. Hultdin, M. et al. (2002) Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood, 99, pp. 2262-2264.
50. Stamatopoulos, K., Belessi, C., Moreno, C., Boudjograh, M., Guida, G. Smilevska, T. et al. (2007) Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood, 109, pp. 259-270.
51. Hillson, J. L., Karr, N. S., Oppliger, I. R., Mannik, M. and Sasso, E. H. (1993) The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A. J Exp Med, 178, pp. 331-336.
52. Bertoni, F., Zucca, E. and Cotter, F. E. (2004) Molecular basis of mantle cell lymphoma. Br J Haematol, 124, pp. 130-140.
53. Bodrug, S. E., Warner, B. J., Bath, M. L., Lindeman, G. J., Harris, A. W. and Adams, J. M. (1994) Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. Embo J, 13, pp. 2124-2130.
54. Lovec, H., Grzeschiczek, A., Kowalski, M. B. and Moroy, T. (1994) Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. Embo J, 13, pp. 3487-3495.
55. Kohlhammer, H., Schwaenen, C., Wessendorf, S., Holzmann, K., Kestler, H. A. Kienle, D. et al. (2004) Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. Blood, 104, pp. 795-801.
56. Rubio-Moscardo, F., Climent, J., Siebert, R., Piris, M. A., Martin-Subero, J. I. Nielander, I. et al. (2005) Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. Blood, 105, pp. 4445-4454.
57. Schraders, M., Pfundt, R., Straatman, H. M., Janssen, I. M., van Kessel, A. G. Schoenmakers, E. F. et al. (2005) Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization. Blood, 105, pp. 1686-1693.
58. Tagawa, H., Karnan, S., Suzuki, R., Matsuo, K., Zhang, X. Ota, A. et al. (2005) Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene, 24, pp. 1348-1358.
59. Rinaldi, A., Kwee, I., Taborelli, M., Largo, C., Uccella, S. Martin, V. et al. (2006) Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma. Br J Haematol, 132, pp. 303-316.
60. Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Krober, A. Bullinger, L. et al. (2000) Genomic Aberrations and survival in chronic lymphocytic leukemia. N Engl J Med, 343, pp. 1910-1916.
61. Aoun, P., Blair, H. E., Smith, L. M., Dave, B. J., Lynch, J. Weisenburger, D. D. et al. (2004) Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Lymphoma, 45, pp. 1595-1603.
62. Parry-Jones, N., Matutes, E., Morilla, R., Brito-Babapulle, V., Wotherspoon, A. Swansbury, G. J. et al. (2007) Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: A study of 60 cases by FISH. Br J Haematol, 137, pp. 117-124.
63. Stilgenbauer, S., Schaffner, C., Winkler, D., Ott, G., Leupolt, E. Bentz, M. et al. (2000) The ATM gene in the pathogenesis of mantle-cell lymphoma. Ann Oncol, 11, pp. 127-130.
64. Flordal Thelander, E, Walsh, S. H., Thorselius, M., Laurell, A., Landgren, O. Larsson, C. et al. (2005) Mantle cell lymphomas with clonal immunoglobulin V(H)3-21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V(H) genes. Mod Pathol, 18, pp. 331-339.
65. Mestre-Escorihuela, C., Rubio-Moscardo, F., Richter, J. A., Siebert, R., Climent, J. Fresquet, V. et al. (2006) Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood, 109, pp. 271-280.